MONARCH and ADMIRAL Interim Analyses: Open-label, Phase 1/2a Studies in US and UK Investigating STK-001, an Antisense Oligonucleotide (ASO), in Children and Adolescents with Dravet Syndrome (DS)

IEC 2023

September 2, 2023